You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 138 No. 9, September 2002 TABLE OF CONTENTS
  Archives
  •  Online Features
  Study
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on HighWire
 •Citing articles on ISI (12)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Dermatologic Disorders, Other
 •Alert me on articles by topic

Frequency and Severity of Systemic Disease in Patients With Subacute Cutaneous Lupus Erythematosus

Dana R. Black, MD; Carlton A. Hornung, PhD, MPH; Paul D. Schneider, MD; Jeffrey P. Callen, MD

Arch Dermatol. 2002;138:1175-1178.

Objective  To compare the frequency and severity of systemic disease in patients with subacute cutaneous lupus erythematosus (SCLE) followed up in a dermatology practice vs patients with systemic lupus erythematosus (SLE) followed up in a rheumatology practice.

Design  Case-control comparison of patients matched for age, sex, and ethnicity.

Setting  University-affiliated dermatology and rheumatology practices.

Patients  Seventy-six patients with SCLE were compared with 24 patients with SLE.

Intervention  All medical records were reviewed and the patients were interviewed.

Main Outcome Measures  Systemic and serologic findings were compared between patients with SCLE and those with SLE.

Results  Hematologic disorders were present in 6 patients (8%) with SCLE and in 13 patients (54%) with SLE (P<.001). Serositis was present in 1 patient (1%) with SCLE and in 3 patients (12%) with SLE (P = .04). Renal involvement was present in 12 patients (16%) with SCLE and in 6 patients (25%) with SLE (P = .36). Antinuclear antibodies were found in 52 patients (68%) with SCLE compared with 23 patients (96%) with SLE (P = .006). Anti-Ro antibodies were found in 37 patients (49%) with SCLE compared with 10 patients (42%) with SLE (P = .64). Other serologic abnormalities (anti–native DNA, anti-Sm antibody, or anti-U1RNP) were present in 6 patients (8%) with SCLE compared with 15 patients (62%) with SLE (P<.001). Photosensitivity was present in 65 patients (86%) with SCLE, compared with 11 patients (46%) with SLE (P<.001).

Conclusions  This analysis reveals a dissimilar frequency of internal organ involvement between patients with SCLE and SLE. Renal disease was similar in frequency and severity, and documented central nervous system involvement was rare in both groups.


From the Divisions of Dermatology (Drs Black and Callen), General Medicine (Dr Hornung), and Rheumatology (Dr Schneider), Department of Medicine, University of Louisville School of Medicine, Louisville, Ky.



THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Acute pancreatitis as initial manifestation of systemic lupus erythematosus and subacute cutaneous lupus erythematosus: report of two cases
Carducci et al.
Lupus 2008;17:695-697.
 

Clinical and laboratory characteristics of Finnish lupus erythematosus patients with cutaneous manifestations
Koskenmies et al.
Lupus 2008;17:337-347.
ABSTRACT  

How Frequently Are Drugs Associated With the Development or Exacerbation of Subacute Cutaneous Lupus?
Callen
Arch Dermatol 2003;139:89-90.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2002 American Medical Association. All Rights Reserved.